Sonic Healthcare USA to Offer Assay to Aid in the Selection of JEMPERLI (dostarlimab-gxly) Therapy in Endometrial Cancer

Sonic Healthcare USA is announced as a Laboratory Testing Partner for National K-12 School Testing Program

Over the last few weeks, our network of clinical laboratories throughout the United States has seen a significant increase in demand for COVID-19 molecular testing. 

A new validation study published today, “Thyroid Cytology Smear Slides: An Untapped Resource for ThyroSeq Testing."

Today, Sonic Healthcare USA (Sonic) was awarded a contract from the National Institutes of Health (NIH) Rapid Acceleration of Diagnostics Advanced Technology Platforms (RADx-ATP) initiative.

Sonic Healthcare USA has launched a multiplex RT-PCR assay that combines testing for SARS-CoV-2 (COVID-19) and Influenza A/B with a single specimen collection.

SARS-CoV-2 Omicron Variant of Concern

Sonic Healthcare USA (Sonic) was selected as one of five commercial laboratories authorized by the US Department of Health and Human Services (HHS)...

This week, Sonic Healthcare USA (Sonic) began testing for Monkeypox (MPXV), using the Centers for Disease Control and Prevention (CDC) Non-variola Orthopoxvirus, high complexity NAAT (RT-PCR) molecular assay...